Clinical Trial

Type 2 Diabetes, Obesity and Cortisol Excess

Study acronym: DOCOR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 24, 2025 (before its estimated December 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
The present observational cross-sectional study is aimed to assess: the hidden hypercortisolism (HidHyCo) prevalence in a sample of Type 2 diabetes (T2D) patients and the clinical characteristics more frequently associated with the HidHyCo presence and the HidHyCo prevalence in an adequate sample of obese patients without T2D and the clinical characteristics more frequently associated with the HidHyCo presence.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-02-26; most recent amendment 2025-03-19.
Trial Details
NCT Number NCT05759637
Lead Sponsor Istituto Auxologico Italiano
Collaborators: University of Siena, Niguarda Hospital, Campus Bio-Medico University, Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy
Conditions Diabetes Mellitus, Type 2, Obesity, Cortisol; Hypersecretion
Enrollment 3,200 participants
Start Date 2022-05-06
Primary Completion 2025-12-06 (estimated)
Study Completion 2025-12-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-24